Affiliation:
1. Research Institute of Clinical and Experimental Rheumatology n.a. A.B. Zborovsky
Abstract
The aim of this work was to study the dependence of the concentration of C-reactive protein in the blood of patients on the severity of systemic lupus erythematosus (SLE). Material and methods. We examined 26 patients with SLE, the comparison group consisted of patients with rheumatoid arthritis (RA) (n = 88). Results. The hsCRP level was significantly higher in patients with a high degree of activity than in patients with minimal and moderate SLE activity (F = 4.409, p = 0.023). In addition, in patients with SLE, a significant direct correlation was found between hsCRP and ESR values (r = 0.409, p = 0.047), antinuclear factor (r = 0.389, p = 0.021), antibodies to double-stranded DNA (r = 0.226, p = 0.033), leukocytes in urine (r = 0.571, p = 0.002), microalbuminuria (r = 0.727, p = 0.017) AsAT (r = 0.428, p = 0.046), and inverse correlation – with the value of blood leukocytes (r = –0.662, p < 0.001). Conclusion. It was found that an increase in the levels of hsCRP in the sera of SLE patients is accompanied by an increase in the degree of disease activity, which indicates a direct correlation between the level of hsCRP and SLE activity. Consequently, the concentration of hsCRP reflects the acute phase response and the intensity of the inflammatory process in SLE.
Publisher
Institute of Cytology and Genetics, SB RAS
Reference14 articles.
1. Moiseev V.S., Martynov A.I., Mukhin N.A. Internal medicine. Moscow: GEOTAR-Media, 2013. 768 p. [In Russian].
2. Yunonin I.E., Butusova S.V., Shilkina N.P. Endothelial activation markers in systemic lupus erythematosus. Tsitokiny i vospalenie = Cytokines and Inflammation. 2011; 10 (1): 9−12. [In Russian].
3. Panafidina T.A., Popkova T.V., Alekberova Z.S., Novikova P.S., Much E.S., Alexandrova Ye.N., Kalashnikova L.N., Nasonov Ye.L. The importance of risk factors and C-reactive protein in the development of atherosclerosis in women with lupus erythematosus. Klinicheskaya meditsina = Clinical Medicine. 2006; 84 (10): 49−54. [In Russian].
4. Sjöwall C., Wetterö J. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins. Clin. Chim. Acta. 2007; 378 (1): 13−23. doi: 10.1016/j.cca.2006.12.002
5. Rezaieyazdi Z., Sahebari M., Hatef M.R., Abbasi В., Rafatpanah H., Afshari J.T., Esmaily H. Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus? Lupus. 2011; 20 (14): 1494−1500. doi: 10.1177/0961203311418706